Training a new breed of clinical triallist

03 February 2022

Cambridge's Experimental Medicine Initiative, working with聽AstraZeneca and GSK, is training聽specialists who can work out at an earlier stage of clinical trials if a treatment is likely to succeed.

Read More

Strategic partner: AstraZeneca

11 November 2019

Scientists at AstraZeneca, a global biopharmaceutical company, have been working with Cambridge 探花直播聽for more than two decades. What are the secrets of their success?

Read More

Drugs: how to pick a winner in clinical trials

26 June 2017

When a drug fails late on in clinical trials it鈥檚 a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an 鈥榓daptive鈥� approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner.聽

Read More